This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector borne disease in the United States. Since 2002, more than 20,000 cases have been reported annually. Numerous organ systems may be affected during the early - disseminated phase (weeks to months after initial tick bite), resulting in neurological complications, joint pain and heart abnormalities. Among patients with confirmed tick-borne infection, coinfection rates as high as 39% have been reported. The most commonly recognized coinfection in most of the United States is Lyme borreliosis and babesiosis, caused by the red blood cell parasite, Babesia microti, accounting for ~80% of coinfections. Moreover, studies of clinical outcomes indicate that patients with acute Babesia coinfection have more severe symptoms and longer duration of illness than patients with Lyme borreliosis alone. Coinfections can modify the immune response and alter the severity of arthritis in animal models. However, little is known about the mechanisms underlying immune regulation and increased arthritis in Lyme borreliosis and babesial coinfections. We have recently shown in a series of experiments that coinfection of B. microti and B. burgdorferi resulted in more severe Lyme arthritis and is correlated with significant reduction of expression of certain key anti-inflammatory cytokines such as Interleukin 10 (IL-10) and IL-13 in a mouse model of Lyme disease. Our efforts have been directed to understand how B. microti regulates the immune response resulting in a more favorable environment for increased arthritis causes by the Lyme disease agent.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR016443-07
Application #
7381285
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2006-07-27
Project End
2007-06-30
Budget Start
2006-07-27
Budget End
2007-06-30
Support Year
7
Fiscal Year
2006
Total Cost
$74,277
Indirect Cost
Name
University of Kansas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
He, Chenchen; Duan, Shaofeng; Dong, Liang et al. (2017) Characterization of a novel p110?-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. Prostate 77:1187-1198
Li, Jiaqin; Wehmeyer, Graham; Lovell, Scott et al. (2016) 1.65?Å resolution structure of the AraC-family transcriptional activator ToxT from Vibrio cholerae. Acta Crystallogr F Struct Biol Commun 72:726-31
Ponnurangam, Sivapriya; Dandawate, Prasad R; Dhar, Animesh et al. (2016) Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Oncotarget 7:3217-32
Freitas, Natalia; Lukash, Tetyana; Dudek, Megan et al. (2015) Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks. Virus Res 205:12-21
Kumaraswamy, E; Wendt, K L; Augustine, L A et al. (2015) BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene 34:4333-46
Freitas, Natalia; Abe, Kenji; Cunha, Celso et al. (2014) Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus. J Virol 88:6255-67
Tang, Yuzhe; Chen, Ruibao; Huang, Yan et al. (2014) Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells. Mol Cancer Ther 13:1526-36
Freitas, Natalia; Cunha, Celso; Menne, Stephan et al. (2014) Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J Virol 88:5742-54
Grogan, Patrick T; Sarkaria, Jann N; Timmermann, Barbara N et al. (2014) Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Invest New Drugs 32:604-17
Alhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory J et al. (2013) Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 4:741-57

Showing the most recent 10 out of 174 publications